Secretin porcine

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Secretin porcine
Accession Number
DB09527
Type
Biotech
Groups
Approved
Biologic Classification
Protein Based Therapies
Other protein based therapies
Description

Secretin porcine stimulates pancreatic and gastric secretions to aid in the diagnosis of pancreatic exocrine dysfunction and the diagnosis of gastrinoma.

Protein chemical formula
Not Available
Protein average weight
Not Available
Sequences
Not Available
Synonyms
  • Pig secretin
  • Porcine secretin
  • Secretin (pig)
  • Secretin (porcine)
  • Secretin (swine)
  • Secretin synthetic porcine
  • Synthetic porcine secretin
Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
Porcine SecretinInjection, powder, lyophilized, for solution16 ug/8mLIntravenousChiRhoClin, Inc.2002-10-012008-09-30Us
Additional Data Available
  • Application Number
    Application Number

    A unique ID assigned by the FDA when a product is submitted for approval by the labeller.

    Learn more
  • Product Code
    Product Code

    A governmentally-recognized ID which uniquely identifies the product within its regulatory market.

    Learn more
International/Other Brands
Secreflo / Secrepan
Categories
UNII
D0L9J6I13I
CAS number
17034-35-4

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteraction
AclidiniumThe therapeutic efficacy of Secretin porcine can be decreased when used in combination with Aclidinium.
AgmatineThe therapeutic efficacy of Secretin porcine can be decreased when used in combination with Agmatine.
AlcuroniumThe therapeutic efficacy of Secretin porcine can be decreased when used in combination with Alcuronium.
AmantadineThe therapeutic efficacy of Secretin porcine can be decreased when used in combination with Amantadine.
AmitriptylineThe therapeutic efficacy of Secretin porcine can be decreased when used in combination with Amitriptyline.
AmobarbitalThe therapeutic efficacy of Secretin porcine can be decreased when used in combination with Amobarbital.
AmoxapineThe therapeutic efficacy of Secretin porcine can be decreased when used in combination with Amoxapine.
Anisotropine methylbromideThe therapeutic efficacy of Secretin porcine can be decreased when used in combination with Anisotropine methylbromide.
AprobarbitalThe therapeutic efficacy of Secretin porcine can be decreased when used in combination with Aprobarbital.
AripiprazoleThe therapeutic efficacy of Secretin porcine can be decreased when used in combination with Aripiprazole.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

References

General References
Not Available
External Links
KEGG Drug
D02021
KEGG Compound
C13523
ChEBI
34972
Wikipedia
Secretin

Clinical Trials

Clinical Trials
Not Available

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
Injection, powder, lyophilized, for solutionIntravenous16 ug/8mL
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Description
Not Available
Kingdom
Organic Compounds
Super Class
Organic Acids
Class
Carboxylic Acids and Derivatives
Sub Class
Amino Acids, Peptides, and Analogues
Direct Parent
Peptides
Alternative Parents
Not Available
Substituents
Not Available
Molecular Framework
Not Available
External Descriptors
Not Available

Drug created on November 30, 2015 12:10 / Updated on August 02, 2019 08:44